ArticleThe oncologist2025

Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer.

Wanwan Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.